GENETIC INVOLVEMENT OF INTERLEUKIN 4 FOR ASTHMA AND IDENTIFICATION OF POTENTIAL PHYTOCHEMICAL SCAFFOLD THROUGH MOLECULAR DOCKING STUDIES
DOI:
https://doi.org/10.22159/ijcpr.2018v10i1.24704Keywords:
Interleukin 4, Single nucleotide polymorphism, Cell signaling pathway, Mutation studies, Protein characterization studies, Pharmacophore, Molecular docking, PhytochemicalsAbstract
Objective: Interleukin 4, an important cytokine, has the major role in the immunomodulatory responses associated with asthma. The present study focused on the involvement of single nucleotide polymorphism variation (SNP) of interleukin 4 (IL4) in the development of disease, asthma and designing small molecules for the inhibition of IL4 through in silico strategy.
Methods: Identification of disease causing SNP will be a wise approach towards the phenotype specific treatment. A human origin deleterious no synonymous SNP of IL4 were found out in the chromosome region 5q31-q33 (rs199929962) (T/C). Proteins of the corresponding nucleotide variation were identified and were subjected to characterization studies for selecting the most appropriate one for further mutational analysis and molecular docking studies.
Results: Influence of microbes on SNP variation of IL4 gene leading to asthma was found to be insignificant by metagenomic studies. Gene responsive drugs were identified through environmental factor analysis. The drug candidates including corticosteroids were subjected to protein interaction studies by in silico means. The pharmacophoric feature derived from drug receptor interaction was utilized for virtual screening on a dataset of anti-inflammatory phytomolecules. The scaffolds of ellagic acid and quercetin were identified as potential nonsteroidal entities which can shield the asthmatic activities.
Conclusion: Developing small molecules using these scaffolds taking interleukin 4 as a target will be an adequate solution for steroid resistant asthma.Downloads
References
Ivana V. Yang, David A. Schwartz epigenetic mechanisms and the development of asthma. J Allergy Clin Immunol 2013;6:1243-55.
Global Strategy for Asthma Management and Prevention; 2016.
RJ Flower. Eleventh gaddum memorial lecture lipocortin and the mechanism of action of the glucocorticoids. Br J Pharmacol 1988;94:987–1015.
J Mullol, A Xaubet, E Lopez, J Roca-ferrer, C Picado. Comparative study of the effects of different gluco-corticosteroids on eosinophil survival primed by cultured epithelial cell supernatants obtained from nasal mucosa and nasal polyps. Thorax 1995;270:270–4.
RS Irwin, ND Richardson. Corticosteroids* The Physician’s perception. Chest 2006;130:41S–53S.
AV Ignal, DM Ilan. A review on SNP and other types of molecular markers and their use in animal genetics. Genet Sel Evol 2002;34:275–305.
JTL Mah, ESH Low, E Lee. In silico SNP analysis and bioinformatics tools : a review of the state of the art to aid drug discovery. Drug Discovery Today 2011;16:800–9.
G Erkel, Hanane Belahmer, Annegret Serwe, Timm Anke, Horst Kunz, Heinz Kolshorn, et al. Oxacyclododecindione, a novel inhibitor of IL-4 signaling from exserohilum rostratum. J Antibiot 2008;61:285–90.
Michael Kabesch, Iren Tzotcheva, David Carr, Claudia Höfler, Stephan K Weiland, Christian Fritzsch, et al. A complete screening of the IL4 gene: novel polymorphisms and their association with asthma and IgE in childhood. J Allergy Clin Immunol 2003;112:893–8.
K Vale. Targeting the JAK-STAT pathway in the treatment of ‘Th2-high’ severe asthma. Future Med Chem 2016;10:4155.
T Tanaka, R Takahashi. Flavonoids and Asthma. Nutrients 2013;5:2128–43.
Barbara Männel, Mariama Jaiteh, Alexey Zeifman, Alena Randakova, Dorothee Möller, Harald Hübner, et al. Structure-guided screening for functionally selective D dopamine receptor ligands from a virtual chemical library structure-guided screening for functionally selective D2 dopamine receptor ligands from a virtual chemical library. ACS Chem Biol 2017;12:2652–61.
Noguchi, Emiko Nukaga-nishio, Yuumi Jian, Zhang Yokouchi, Yukako Kamioka, Masashi Yamakawa-kobayashi, et al. Haplotypes of the 5 ؅ region of the IL-4 gene and SNPs in the intergene sequence between the IL-4 and IL-13 genes are associated with atopic asthma. Hum Immunol 2001;8859:1251–7.
Sherry S, T Ward, M Kholodov, M Baker, J Phan, L Smigielski, et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 2001;29:308–11.
I Adzhubei, DM Jordan, SR Sunyaev. Predicting functional effect of human missense mutations using polyphen-2 predicting the effect of a single-residue substitution on protein structure and function using the polyphen-2 WEB. Current Protocols in Human Genetics 2013;7:1-41.
PCNg, S Henikoff. Accounting for human polymorphisms predicted to affect protein function. Genome Res 2002;12:436–46.
Simov, Vladimir Deshmukh, Sujal V Dinsmore, Christopher J Elwood, Fiona Fernandez, Rafael B Garcia, et al. Lung microbiome analysis in steroid-naïve asthma patients by using whole sputum. Korean Acad Tuberc Respir Dis 2016;3536:165–78.
AB Mukherjee, Z Zhang. Allergic asthma: influence of allergic asthma: a complex syndrome. J Biol Chem 2011;286:32883–9.
M Ryan, M Diekhans, S Lien, Y Liu, R Karchin. LS-SNP/PDB: annotated non-synonymous SNPs mapped to protein data bank structures. Struct Bioinf 2009;25:1431–2.
Gasteiger, Elisabeth Hoogland, Christine Gattiker, Alexandre Duvaud, Séverine Wilkins, Marc R Appel, et al. Protein identification and analysis tools on the ExPASy server. Proteomics Protocols Handbook; 2005. p. 571-605.
DG Geourjon. SOPM: a self-optimized method for protein secondary structure prediction. Protein Eng 1994;7:157–64.
AB Pernis, PB Rothman. JAK-STAT signaling in asthma. J Clin Invest 2002;109:1279–83.
Published
How to Cite
Issue
Section
